# ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes

> **NCT04933851** · PHASE2 · RECRUITING · sponsor: **Scripps Whittier Diabetes Institute** · enrollment: 250 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **BEHAVIORAL:** ACT1VATE
- **BEHAVIORAL:** DSME/S

## Key facts

- **NCT ID:** NCT04933851
- **Lead sponsor:** Scripps Whittier Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-25
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04933851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04933851, "ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04933851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*